Skip to main content
    S

    Scienture Holdings, Inc. (SCNX)

    Official site

    HEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ

    $2.78
    -0.21 (-7.02%)

    Market Cap: $4.91M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Scienture Holdings, Inc. (SCNX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Scienture Holdings (SCNX) has a market cap of $4.91M and an enterprise value of $10.99M. It kept -2715.93% of revenue as net income over the last 12 months. Its share count is up 110.62% from a year earlier.

    Total Valuation

    Enterprise value is 123.77% above the market cap, as debt exceeds cash.

    Market Cap$4.91M
    Enterprise Value$10.99M
    Latest price (Nov 17, 2026)$2.78

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 95.97% in the quarter ended Sep 30, 2026 and shrank 17.97% a year over 2 years.

    Shares Outstanding1.60M
    Shares Change (YoY)+110.62%
    Shares Change (QoQ)-95.97%
    Share Count Growth (2Y CAGR)-17.97%

    Valuation Ratios

    The price to sales ratio is 3.0x. Its year-end P/S ranged from 6.7x to 369.8x from 2019 to 2025.

    P/S Ratio3.0x
    Forward P/S1.3x

    Price Statistics

    The stock is down 82.72% over 52 weeks and trades 41.23% below its 50-day average.

    Beta (1Y)1.68
    52-Week Change-82.72%
    1-Month Change-4.79%
    3-Month Change-76.55%
    6-Month Change-71.49%
    5-Year Change-99.80%
    10-Year Change-99.78%
    Total Return (1Y)-82.72%
    Total Return (3Y CAGR)-66.49%
    Total Return (5Y CAGR)-66.78%
    Return vs SPY (1Y)-93.84%
    Max Drawdown (1Y)-82.99%
    Max Drawdown (3Y)-99.46%
    Sharpe Ratio (1Y)-1.69
    Correlation with SPY (1Y)0.23
    50-Day Average$4.73
    200-Day Average$8.63
    52-Week Range$2.64 to $18.75
    RSI (14 Days)30.7
    Average Volume (20 Days)25.74K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.10x current liabilities, and total debt is 0.18x shareholder equity.

    Current Ratio1.10x
    Quick Ratio0.97x
    Debt / Equity0.18x
    Interest Coverage-25.00x

    Returns and Efficiency

    Return on invested capital is -56.16% and return on equity is -68.70% over the last 12 months.

    Return on Equity (ROE)-68.70%
    Return on Assets (ROA)-46.29%
    Return on Invested Capital (ROIC)-56.16%
    Return on Capital Employed (ROCE)-51.82%
    ROA (5Y Average)-76.12%
    Asset Turnover0.02x
    Inventory Turnover0.53x
    Receivables Turnover1.14x
    Cash Conversion Cycle-1880 days

    Scores

    SCNX has an Altman Z-Score of -2.92, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-2.92
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.49M over the last 12 months is up 127.40% from the 12 months before.

    Revenue$1.49M
    Revenue Growth (YoY)+127.40%
    Gross Profit$1.17M
    Operating Income-$41.43M
    Pretax Income-$42.35M
    Net Income-$40.35M
    EBITDA-$38.51M
    EBIT-$41.00M
    Reported EPS (TTM)-$5.03

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 67.38% of the $87.18M in total assets.

    Cash and Equivalents$4.75M
    Total Debt$10.83M
    Net Debt$6.08M
    Net Debt Per Share$3.81
    Working Capital$772.60K
    Shareholder Equity$58.74M
    Book Value Per Share$36.78
    Tangible Book Value-$10.87M
    Total Assets$87.18M
    Total Liabilities$28.44M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$14.69M
    FCF Per Share-$8.94
    Depreciation and Amortization$2.49M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2788.53%.

    Gross Margin78.46%
    Operating Margin-2788.53%
    Pretax Margin-2850.19%
    Net Margin-2715.93%
    EBITDA Margin-2591.63%
    EBIT Margin-2759.31%
    Gross Margin (5Y Average)37.33%

    Growth

    Revenue fell 65.21% a year over 3 years.

    Revenue Growth (3Y CAGR)-65.21%
    Revenue Growth (5Y CAGR)-52.10%
    Book Value Per Share Growth (2Y CAGR)+41.10%

    Revenue and profit by year

    Dividends and Yields

    SCNX does not pay a dividend.

    Buyback Yield-334.75%
    Shareholder Yield-334.75%

    Stock Splits

    The last split was a 1-for-25 reverse split on Oct 5, 2026.

    Last Split DateOct 5, 2026
    Split TypeReverse split
    Split Ratio1:25

    Peer Position

    Against 4 similar companies, SCNX has the 2nd highest P/S.

    P/S Ratio3.0x vs 1.4x median
    ROIC-56.16% vs -32.90% median
    Revenue Growth (Trailing 4 Quarters, YoY)+127.40% vs -98.74% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 498.71% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+498.71%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SCNX

    What is SCNX's market cap?

    Scienture Holdings has a market cap of $4.91M. Its enterprise value, which adds debt and subtracts cash, is $10.99M.

    How many shares of SCNX are outstanding?

    Scienture Holdings has 1.60M shares outstanding. The count is up 110.62% from a year earlier.

    Does SCNX pay a dividend?

    No. Scienture Holdings does not pay a dividend.

    How much debt does SCNX have?

    Scienture Holdings has $10.83M of total debt and $4.75M of cash and equivalents, a net debt position of $6.08M.